Oxford BioMedica PLC (OXB) — Capital Reinvestment Ratio
Latest as of June 2025:
0.64x
Oxford BioMedica PLC (OXB) has a Capital Reinvestment Ratio of 0.64x as of June 2025, meaning it reinvests 1% of its operating cash flow (GBX2.35 Million) in capital expenditures (GBX1.51 Million). See OXB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.64x
Capex / Operating Cash Flow
Operating Cash Flow
GBX2.35 Million
GBX
Capital Expenditures
GBX1.51 Million
GBX
Data as of
Jun 2025
Most recent filing
Oxford BioMedica PLC Capital Reinvestment Ratio (2007–2021)
This chart tracks Oxford BioMedica PLC's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Oxford BioMedica PLC (2007–2021)
Year-by-year Capital Reinvestment Ratio for Oxford BioMedica PLC from 2007 to 2021. For live market cap and broader valuation context, see Oxford BioMedica PLC market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.37x | GBX25.45 Million | GBX9.46 Million | ▼ -91.3% |
| 2020 | 4.29x | GBX3.12 Million | GBX13.36 Million | ▲ +443.6% |
| 2018 | 0.79x | GBX12.87 Million | GBX10.15 Million | ▲ +19.3% |
| 2017 | 0.66x | GBX2.98 Million | GBX1.97 Million | ▲ +431.1% |
| 2009 | 0.12x | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX4.73 Million | GBX421.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow